echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Up to 89.6% reduction 7.45 million consumables negotiated results announced (attached list)

    Up to 89.6% reduction 7.45 million consumables negotiated results announced (attached list)

    • Last Update: 2020-09-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On August 18, according to Qinghai Daily News, Qinghai Provincial Medical Security Bureau organized the province's public medical institutions medical supplies centralized procurement alliance, to complete the retention needles and infusions centralized belt procurement work.
    Shandong Weigao, Bidi medical equipment and other 64 foreign medical supplies production enterprises to participate in the public bidding, Shandong Weigao, Suzhou Linhua and Belang Medical and other 8 weapons enterprises were selected, the final selection price dropped significantly.
    According to preliminary estimates, the maximum decline of the retention needle was 88.3%, the lowest decline was 68.3%, the average decrease was 78.9%, and the annual savings of 42.56 million yuan were expected;
    expected that in mid-September, the province's public medical institutions at all levels to formally implement the retention needle and infusion in the election results, to ensure that the results of the election in a timely manner.
    according to Cypress Blue equipment combing, Qinghai Province lien needles in 2020 total procurement volume of about 1.301 million units, infusion 2020 procurement volume of about 9.344 million units.
    procurement announcement shows that the first year agreed procurement volume according to the province's public medical institutions at all levels reported 70% of the total procurement volume in 2020, that is, the two types of supplies procurement volume of about 7.4515 million units.
    At the same time, it is worth noting that this volume of procurement is not simply to the price as the criteria for selection, according to the above-mentioned procurement announcement, while declaring enterprises in 3 and above, according to the enterprise product quality, reputation, service and price indicators for comprehensive scoring, the highest score for the selection, score second for the alternative, the score appears side by side, the enterprise size by the former selected.
    17 July and 13 August, Qinghai Province's centralized procurement network for pharmaceuticals and medical supplies released the results of the selected enterprises for the volume procurement of retention needles and infusions, respectively (see the end of the article).
    price reduction of 81.97 percent, the results of the negotiations in the province were announced on August 18, Anhui Provincial Health Insurance Bureau announced that on August 14, Anhui Provincial Health Insurance Bureau completed the province's public medical institutions the second batch of high-value medical supplies centralized belt procurement.
    81.97 percent for 240 products in the final orthopaedic joint category and 46.75 percent for 82 products in the pacemaker category.
    according to the 2019 province's orthopaedic joints and pacemaker products online procurement, it is expected that after negotiations, the annual savings of the two types of products are 588 million yuan and 0.83 billion yuan, respectively.
    July 28, Anhui Provincial Health Insurance Bureau issued the "Anhui Province public medical institutions high-value medical supplies centralized belt procurement negotiation bargaining implementation plan" shows that the reference to the successful product purchase volume of the same period last year, public medical institutions and negotiated successful products signed a volume purchase and sale contract, the annual procurement volume is not less than 80% of the reference period of the product procurement volume, and ensure that within one year to complete the annual procurement task.
    understood that, prior to this, in July 2019, Anhui to public medical institutions procurement complex as the main body, joint orthopaedic implants (spine) class, ophthalmology (artificial crystal) category product volume procurement.
    orthopaedic spinal materials overall average price reduction of 53.4%, the largest decline of 95% for individual components, the average price reduction for national products category 55.9%, the average price reduction for imported categories 40.5%.
    average price reduction of 20.5% for the chinese and Chinese artificial crystal categories, 18.1% for the national product category and 20.9% for the import category.
    for the largest price reduction orthopaedic joint products, in addition to Anhui, there are many other regions have completed negotiations to reduce prices.
    , according to the Nanjing Daily News, on September 29, 2019, Jiangsu Province completed the second round of negotiations on the Supplies Alliance, with an average decline of 47.20% and a maximum decrease of 76.70%.
    On July 7 this year, medical supplies centralized procurement of medical supplies in public medical institutions in Minnan County, Guizhou Province was held, and finally 4 enterprises were shortlisted for orthopaedic implantation (spinal) supplies suppliers, 3 enterprises were shortlisted for orthopaedic implants (joints) supplies suppliers, spinal consumables fell by up to 70%, joint supplies by up to 66%.
    July 10, The Fujian Provincial Health Insurance Bureau issued a notice of the results of the centralized belt purchase of consumables, compared with the current purchase price in Fujian Province, the average reduction of artificial hip joints was 35.32 percent and the average decline of artificial knee joints was 32.12 percent.
    July 30-31, Jiangsu Province completed the third round of supplies alliance negotiations, the average reduction of the initial replacement of artificial knee joints 67.3%, the highest decline of 81.9%.
    orthopaedic implant enterprise Top20 can be seen from the above information, orthopaedic joint supplies have become the preferred variety of multi-strip quantity procurement.
    , orthopaedic medical device products to implant supplies-based, in the entire medical device industry belongs to the top five products sales.
    according to China Industrial Information Network data, China's orthopaedic equipment market has exceeded 50 billion yuan, and there is still a large room for growth.
    2018, China's orthopaedic equipment market is about 51.5 billion yuan, only 37.5 percent of the U.S. market.
    China's orthopaedic device market grew at an annual rate of about 16.3% in 2018, while the U.S. orthopaedic equipment market grew at a CAGR of 2.8% in 2015-2017, and China's growth rate was close to six times that of the U.S. market.
    according to the Institute of Forward-Looking Industry, orthopaedic implant market can be divided into trauma, spine, joint, and other.
    2018, the top three markets will have a market share of 85.50%.
    , the spine overtook trauma as the largest segment, accounting for 29.01 per cent, trauma was second at 28.63 per cent and joints at 27.86 per cent.
    with the improvement of china's residents' consumption capacity, the improvement of the domestic medical insurance system and the overall improvement of the level of treatment of clinicians, China's market share of spinal and joint consumables products will be further improved.
    China Industry Information Network data show that in 2018 in China's orthopaedic implant market, six of the top 20 are imported manufacturers, of which top5 are imported manufacturers, respectively, Johnson and Johnson 13.11%, Jemma Bangmei 8.67%, Stryker 6.56%, Medtron 5.14%, Shilehui 4.4%, concentration CR5 for 37.93%, the absolute advantage.
    and the domestic Vigo shares with 4.05% market share followed closely behind, Dabo Medical 2.86% ranked second in domestic, domestic companies are relatively small.
    from the point of view of concentration, CR20 market share of 57.34 percent, it can be seen that there are still many income in the millions of small orthopaedic manufacturers, with its geographical advantages, deep cultivation in the local area.
    source: China Industrial Information Network Annex:
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.